61 related articles for article (PubMed ID: 24608273)
1. The tumor-suppressing activity of the prenyl diphosphate synthase subunit 2 gene in lung cancer cells.
Chen P; Zhang Y; Polireddy K; Chen Q
Anticancer Drugs; 2014 Aug; 25(7):790-8. PubMed ID: 24608273
[TBL] [Abstract][Full Text] [Related]
2. Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer.
Chen P; Yu J; Knecht J; Chen Q
Cancer Epidemiol; 2013 Apr; 37(2):166-71. PubMed ID: 23312889
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of PDSS2, prenyl diphosphate synthase, subunit 2, in gastric cancer tissue and the SGC7901 cell line.
Chen P; Zhao SH; Chu YL; Xu K; Zhu L; Wu Y; Song J; Cao CX; Xue X; Niu YY
Anticancer Drugs; 2009 Feb; 20(2):141-8. PubMed ID: 19209031
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a novel melanoma tumor suppressor gene on human chromosome 6q21.
Fung JM; Smith R; Brown MA; Lau SH; Xie D; Lau GK; Guan XY
Clin Cancer Res; 2009 Feb; 15(3):797-803. PubMed ID: 19188149
[TBL] [Abstract][Full Text] [Related]
5. Sp1 Mediates the Constitutive Expression and Repression of the PDSS2 Gene in Lung Cancer Cells.
Hu L; Chen Q; Wang Y; Zhang N; Meng P; Liu T; Bu Y
Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31783675
[TBL] [Abstract][Full Text] [Related]
6. Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma.
Huang W; Gao F; Li K; Wang W; Lai YR; Tang SH; Yang DH
World J Gastroenterol; 2015 Mar; 21(10):3055-65. PubMed ID: 25780306
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.
Kanda M; Nomoto S; Oya H; Hashimoto R; Takami H; Shimizu D; Sonohara F; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Murotani K; Fujiwara M; Kodera Y
J Exp Clin Cancer Res; 2014 Oct; 33(1):88. PubMed ID: 25330808
[TBL] [Abstract][Full Text] [Related]
8. Cerebellar defects in Pdss2 conditional knockout mice during embryonic development and in adulthood.
Lu S; Lu LY; Liu MF; Yuan QJ; Sham MH; Guan XY; Huang JD
Neurobiol Dis; 2012 Jan; 45(1):219-33. PubMed ID: 21871565
[TBL] [Abstract][Full Text] [Related]
9. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
10. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers.
Dosaka-Akita H; Hommura F; Fujita H; Kinoshita I; Nishi M; Morikawa T; Katoh H; Kawakami Y; Kuzumaki N
Cancer Res; 1998 Jan; 58(2):322-7. PubMed ID: 9443412
[TBL] [Abstract][Full Text] [Related]
12. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D
Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152
[TBL] [Abstract][Full Text] [Related]
13. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
Wang ZX; Lu BB; Yang JS; Wang KM; De W
J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
[TBL] [Abstract][Full Text] [Related]
15. Effect of protein-tyrosine phosphatase 4A3 by small interfering RNA on the proliferation of lung cancer.
Lian YX; Chen R; Xu YH; Peng CL; Hu HC
Gene; 2012 Dec; 511(2):169-76. PubMed ID: 23036709
[TBL] [Abstract][Full Text] [Related]
16. Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer.
Lu L; Zhang X; Zhang B; Wu J; Zhang X
Int J Biochem Cell Biol; 2013 Nov; 45(11):2530-40. PubMed ID: 23974008
[TBL] [Abstract][Full Text] [Related]
17. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
Wong JC; Bathina M; Fiscus RR
J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
[TBL] [Abstract][Full Text] [Related]
18. CD59 is overexpressed in human lung cancer and regulates apoptosis of human lung cancer cells.
Li B; Lin H; Fan J; Lan J; Zhong Y; Yang Y; Li H; Wang Z
Int J Oncol; 2013 Sep; 43(3):850-8. PubMed ID: 23835643
[TBL] [Abstract][Full Text] [Related]
19. [Effect of DAPK1 gene transfection on high-metastasis non-small lung cancer cell PGCl3].
Zhang HT; Zhu ZY; Feng ZL; Li XY; Li MY; Ma JQ; Liang NC
Ai Zheng; 2004 May; 23(5):497-501. PubMed ID: 15142442
[TBL] [Abstract][Full Text] [Related]
20. Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer.
Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Albring KF; Huber O; Petersen I
Carcinogenesis; 2012 Oct; 33(10):1863-70. PubMed ID: 22791817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
